Anti-gene strategies to down-regulate gene expression in mammalian cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current pharmaceutical design

• Publication date

  2004-02-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612043452983PMID 15032705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.

  2003cited by this paper
• Inhibition of Gene Expression by Peptide Nucleic Acids in Cultured Cells

  2003cited by this paper
• LNA: a versatile tool for therapeutics and genomics.

  2003cited by this paper
• Triplex-forming oligonucleotides as modulators of gene expression.

  2003cited by this paper
• Cellular delivery of peptide nucleic acid (PNA).

  2003cited by this paper
• Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.

  2002cited by this paper
• Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.

  2002cited by this paper
• Genetic and epigenetic alterations in colon cancer.

  2002cited by this paper
• Oligonucleotide Conjugates as Potential Antisense Drugs with Improved Uptake, Biodistribution, Targeted Delivery, and Mechanism of Action

  2002cited by this paper
• Nucleic acid aptamers in cancer medicine

  2002cited by this paper
• Triplex-forming oligonucleotides: principles and applications

  2002cited by this paper
• Liposome-Mediated Delivery of Oligodeoxynucleotides In Vivo

  2002cited by this paper
• Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene.

  2002cited by this paper
• Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids.

  2002cited by this paper
• Specific Inhibition of ICAM-1 Expression Mediated by Gene Targeting with Triplex-forming Oligonucleotides*

  2002cited by this paper
• Synthesis and properties of triple helix-forming oligodeoxyribonucleotides containing 7-chloro-7-deaza-2'-deoxyguanosine.

  2001cited by this paper
• RNA Interference and Small Interfering RNAs

  2001cited by this paper
• Targeting double stranded DNA with peptide nucleic acid (PNA).

  2001cited by this paper
• Gene targeting via triple-helix formation.

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif.

  2001cited by this paper
• Targeted Gene Knockout by 2′-O-Aminoethyl Modified Triplex Forming Oligonucleotides*

  2001cited by this paper
• 2'-O,4'-C-Methylene bridged nucleic acid (2',4'-BNA): synthesis and triplex-forming properties.

  2001cited by this paper
• Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.

  2001cited by this paper
• Antisense therapy in oncology: new hope for an old idea?

  2001cited by this paper
• Triple, MPEG-conjugated, helix-forming oligonucleotides (TRIPEGXs): liquid-phase synthesis of natural and chimeric "all-purine" sequences linked to high molecular weight poly(ethylene glycols).

  2001cited by this paper
• Triplex forming oligonucleotides: sequence-specific tools for gene targeting.

  2001cited by this paper
• Oligonucleotide-based strategies to reduce gene expression.

  2001cited by this paper
• Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination.

  2001cited by this paper
• Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.

  2001cited by this paper
• Nuclease Resistance and RNase H Sensitivity of Oligonucleotides Bridged by Oligomethylenediol and Oligoethylene Glycol Linkers

  2001cited by this paper
• Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?

  2000cited by this paper
• Downregulation of c-Ki-ras Promoter Activity by Triplex-Forming Oligonucleotides Endogenously Generated in Human 293 Cells

  2000cited by this paper
• Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates.

  2000cited by this paper
• Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.

  2000cited by this paper
• Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies

  2000cited by this paper
• Catalytic nucleic acids: from lab to applications.

  2000cited by this paper
• Inhibition of gene expression and cell proliferation by triple helix-forming oligonucleotides directed to the c-myc gene.

  2000cited by this paper
• Triplex-forming molecules for modulation of DNA information processing.

  2000cited by this paper
• Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future

  2000cited by this paper
• Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal

  2000cited by this paper
• Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.

  2000cited by this paper
• In Vivo Expression of Single-Stranded DNA in Mammalian Cells with DNA Enzyme Sequences Targeted to C-raf

  2000cited by this paper
• Selective Inhibition of Monocyte Chemoattractant Protein-1 Gene Expression in Human Embryonal Kidney Cells by Specific Triple Helix-Forming Oligonucleotides1

  2000cited by this paper
• Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.

  1999cited by this paper
• Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.

  1999cited by this paper
• Oligonucleotide conjugated to linear and branched high molecular weight polyethylene glycol as substrates for RNase H.

  1999cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• Cellular uptake of adamantyl conjugated peptide nucleic acids.

  1999cited by this paper
• Triple helix formation and the antigene strategy for sequence-specific control of gene expression.

  1999cited by this paper
• A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons.

  1998cited by this paper
• Recognition of the four Watson–Crick base pairs in the DNA minor groove by synthetic ligands

  1998cited by this paper
• PD-loop: a complex of duplex DNA with an oligonucleotide.

  1998cited by this paper
• An RNA oligonucleotide corresponding to the polypyrimidine region of the rat alpha 1(I) procollagen promoter forms a stable triplex and inhibits transcription.

  1998cited by this paper
• Targeted gene knockout mediated by triple helix forming oligonucleotides

  1998cited by this paper
• Triple helices formed at oligopyrimidine*oligopurine sequences with base pair inversions: effect of a triplex-specific ligand on stability and selectivity.

  1998cited by this paper
• Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells.

  1998cited by this paper
• Rational design of a triple helix-specific intercalating ligand.

  1998cited by this paper
• Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

  1998cited by this paper
• Spermine conjugated peptide nucleic acids (spPNA): UV and fluorescence studies of PNA-DNA hybrids with improved stability.

  1997cited by this paper
• Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.

  1997cited by this paper
• Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine.

  1997cited by this paper
• Morpholino Antisense Oligomers: Design, Preparation, and Properties

  1997cited by this paper
• A 15-base acridine-conjugated oligodeoxynucleotide forms triplex DNA with its IL-2R alpha promoter target with greatly improved avidity.

  1997cited by this paper
• Conjugates of oligonucleotides with triplex-specific intercalating agents. Stabilization of triple-helical DNA in the promoter region of the gene for the alpha-subunit of interleukin 2 (IL-2R alpha).

  1997cited by this paper
• Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake.

  1997cited by this paper
• Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides.

  1997cited by this paper
• Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.

  1997cited by this paper
• Contrasting effects of PNA invasion of the chimeric DMMYC gene on transcription of its myc and PVT domains.

  1997cited by this paper
• Nucleocytoplasmic Transport

  1996cited by this paper
• Antisense oligonucleotides: towards clinical trials.

  1996cited by this paper
• Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.

  1996cited by this paper
• POSITIVELY CHARGED OLIGONUCLEOTIDES OVERCOME POTASSIUM-MEDIATED INHIBITION OF TRIPLEX DNA FORMATION. † 847

  1996cited by this paper
• Oligonucleotide directed triple helix formation.

  1996cited by this paper
• Enhanced peptide nucleic acid binding to supercoiled DNA: possible implications for DNA "breathing" dynamics.

  1996cited by this paper
• Mechanism of oligonucleotide release from cationic liposomes.

  1996cited by this paper
• In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides.

  1996cited by this paper
• Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.

  1995cited by this paper
• Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells.

  1995cited by this paper
• Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation

  1995cited by this paper
• Origins of the large differences in stability of DNA and RNA helices: C-5 methyl and 2'-hydroxyl effects.

  1995cited by this paper
• Overcoming potassium-mediated triplex inhibition.

  1995cited by this paper
• Inhibition of Gene Expression by Triple Helix Formation in Hepatoma Cells (*)

  1995cited by this paper
• Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid.

  1995cited by this paper
• Incorporation of 2'-deoxy-6-thioguanosine into G-rich oligodeoxyribonucleotides inhibits G-tetrad formation and facilitates triplex formation.

  1995cited by this paper
• DNA-like double helix formed by peptide nucleic acid

  1994cited by this paper
• Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand.

  1994cited by this paper
• Different conformational families of pyrimidine.purine.pyrimidine triple helices depending on backbone composition.

  1994cited by this paper
• Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.

  1994cited by this paper
• Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotides.

  1994cited by this paper
• Synthesis and properties of oligodeoxyribonucleotide-polyethylene glycol conjugates.

  1994cited by this paper
• Sequence specific inhibition of DNA restriction enzyme cleavage by PNA.

  1993cited by this paper
• Monovalent cation effects on intermolecular purine-purine-pyrimidine triple-helix formation.

  1993cited by this paper
• Oligonucleotide Pharmacotherapy: An Antigene Strategy

  1993cited by this paper
• Stability of triple helices containing RNA and DNA strands: experimental and molecular modeling studies.

  1993cited by this paper
• Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

  1993cited by this paper
• PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules

  1993cited by this paper
• An anti-parallel triple helix motif with oligodeoxynucleotides containing 2'-deoxyguanosine and 7-deaza-2'-deoxyxanthosine.

  1993cited by this paper
• Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

  1992cited by this paper
• Antisense and antigene properties of peptide nucleic acids.

  1992cited by this paper

• Anticancer activity of HMGA 1 promoter targeting triplex forming oligonucleotide in HeLa cell line

  2018cites this paper
• Oligonucleotide analogues with cationic backbone linkages

  2018cites this paper
• Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer

  2017cites this paper
• Enzymatically Cleavable siRNA Prodrugs: a New Paradigm for the Intracellular Delivery of RNA‐Based Therapeutics

  2015cites this paper
• NAA-modified DNA oligonucleotides with zwitterionic backbones: stereoselective synthesis of A–T phosphoramidite building blocks

  2015cites this paper
• Optimization of the Formulation and Design of Oligonucleotide-based Pharmaceuticals for the Purpose of Gene Therapy

  2012influential citation
• Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges.

  2011cites this paper
• Stereoselective synthesis of uridine-derived nucleosyl amino acids.

  2011cites this paper
• Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells.

  2010cites this paper
• Site-Specific DNA Photocleavage and Photomodulation by Oligonucleotide Conjugates

  2010cites this paper
• Gene targeting and expression modulation by peptide nucleic acids (PNA).

  2010cites this paper
• Terminal and progenitor lineage-survival oncogenes as cancer markers.

  2008cites this paper
• Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene.

  2008cites this paper
• Chirality as a tool in nucleic acid recognition: principles and relevance in biotechnology and in medicinal chemistry.

  2007cites this paper
• Peptide nucleic acids with a structurally biased backbone: effects of conformational constraints and stereochemistry.

  2007cites this paper
• Recent developments in delivery of nucleic acid-based antiviral agents.

  2006cites this paper
• Repair of Genome Destabilizing Lesions

  2005cites this paper
• Bioplex technology: novel synthetic gene delivery pharmaceutical based on peptides anchored to nucleic acids.

  2005cites this paper
• DNA drug design for cancer therapy.

  2005cites this paper
• alpha-Hydroxy-2-nitrobenzylphosphonat modifizierte Oligonucleotide : Synthese, Eigenschaften und neue Synthesekonzepte

  2005cites this paper
• Dde-protected PNA monomers, orthogonal to Fmoc, for the synthesis of PNA–peptide conjugates

  2005cites this paper
• REVIEW Repair of Genome Destabilizing Lesions

  2005cites this paper